Massage, Oncology, Pain, Anxiety, Feasibility
IMPACT
The Impact of Massage Therapy on Pain and Anxiety in Patients With Gynecologic Cancer While Receiving Infusion
1 other identifier
interventional
24
1 country
1
Brief Summary
The goal of this clinical trial is to determine the feasibility of studying massage therapy in patients with gynecologic cancers while receiving infusion treatments. The central hypothesis is that it is feasible to implement a massage intervention study in an infusion center at an academic hospital, and measure pain and anxiety in patients with gynecological cancer. The main questions it aims to answer are: Can investigators evaluate feasibility to conduct a study from a design standpoint? Can investigators assess the use of randomization, blinding of assessors, potential to control the study with an attention group, and recruitment/retention processes? Can investigators successfully collect outcome measures of pain and anxiety, pre/post intervention? Researchers will investigate degree of resources needed, such as massage therapists, assessors, and timing of delivery intervention. Assess positive/negative effects on target population determining massage modality and anatomical location. Researchers will compare massage therapy to an attention control group, to see if massage therapy works to treat pain and anxiety in patients with cancer. Establish variability in outcome measures. Participants will: Be randomized and receive either massage therapy or attention control over the course of three consecutive infusion therapy treatments. Each infusion therapy treatment occurs every 2-4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 30, 2026
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2026
Study Completion
Last participant's last visit for all outcomes
October 1, 2026
May 11, 2026
March 1, 2026
4 months
March 16, 2026
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment feasibility
Number of participants enrolled within the recruitment period.
6 months
Retention
Number of participants completing the study.
6 months
Randomization
Number of participants randomized
6 months
Percentage of accessors successful blinded
Assessors will be answering yes or no to the questionnaire and percentage will be calculated.
6 months
Number of participants that completed 3 or more sessions
Adherence is defined by participant completing 3 or more sessions.
6 months
Secondary Outcomes (3)
Change in Defense and Veterans Pain Rating Scale (DVPRS)
Pre and post infusion therapy treatment (Up to 9 weeks)
Change in State-Trait Anxiety Inventory (STAI)
Pre and post infusion therapy treatment (Up to 9 weeks)
Temporal Summation, Pain Threshold using von Frey Monofilaments
Pre and Post infusion therapy treatment (Up to 9 weeks)
Study Arms (2)
Attention Control, No Massage Therapy
PLACEBO COMPARATORAttention Control, No Massage Therapy
Massage Therapy
EXPERIMENTALMassage Therapy
Interventions
Gynecologic patient receiving an infusion will receive massage therapy for 15-20 minutes. The patient will have a choice of a hand, foot, or posterior neck and shoulder Swedish massage.
Massage therapist sits with gynecologic patient receiving an infusion asking questions for no more than 15 minutes.
Eligibility Criteria
You may qualify if:
- Patients with gynecologic cancer receiving active treatment of infusion, including but not limited to chemotherapy, immunotherapy, antibiotics, and blood.
- Patients with gynecological cancer undergoing an infusion for the first time.
You may not qualify if:
- Patient with gynecologic cancer that has received infusion therapy anytime within the past 2 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jill Colelead
- Massage Therapy Foundationcollaborator
Study Sites (1)
University of Kentucky
Lexington, Kentucky, 40506, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jill S Cole, MA, LMT, BCTMB
University of Kentucky, Integrative Medicine and Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 16, 2026
First Posted
March 30, 2026
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
May 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share